A prevalent, multiresistant clone of Acinetobacter baumannii in southeast England

Journal of Hospital Infection

Volumn 58, Issue 3, 2004, Pages 170-179

  Turton, J F ^a   Kaufmann, M E ^a   Warner, M ^a   Coelho, J ^a   Dijkshoorn, L ^b   van der Reijden, T ^b   Pitt, T L ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acinetobacter baumannii; Amplified fragment length polymorphism; Intensive care units; Multiresistant; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLONE; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SPUTUM; UNITED KINGDOM; WOUND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DNA FINGERPRINTING; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INFECTION CONTROL; LONDON; MICROBIAL SENSITIVITY TESTS; PREVALENCE;

EID: 7744225279     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.05.011     Document Type: Article

References (37)

1. Theaker C. Azadian B. Soni N. The impact of Acinetobacter baumannii in the intensive care unit Anaesthesia 58 2003 271-274 doi:10.1046/j.1365-2044.2003.30403.x
2. Wang S.H. Sheng W.H. Chang Y.Y. et al. Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit J Hosp Infect 53 2003 97-102 doi:10.1053/jhin.2002.1348
3. Simor A.E. Lee M. Vearncombe M. et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: Risk factors for acquisition and management Infect Control Hosp Epidemiol 23 2002 261-267
4. Roberts S.A. Findlay R. Lang S.D. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit J Hosp Infect 48 2001 228-232 doi:10.1053/jhin.2001.0985
5. Landman D. Quale J.M. Mayorga D. et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned Arch Intern Med 162 2002 1515-1520
6. Melamed R. Greenberg D. Porat N. et al. Successful control of an Acinetobacter baumannii outbreak in a neonatal intensive care unit J Hosp Infect 53 2003 31-38 doi:10.1053/jhin.2002.1324
7. Dalla Costa L.M. Coelho J.M. Souza H.A.P.H.M. et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 enzyme in Curitiba, Brazil J Clin Microbiol 41 2003 3403-3406
8. Barbolla R.E. Centron D. Di Martino A. et al. Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City Diagn Microbiol Infect Dis 45 2003 261-264
9. Dijkshoorn L. Aucken H. Gerner-Smidt P. et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods J Clin Microbiol 34 1996 1519-1525
10. Manuel R.J. Yen Shin G. Farrag N. Holliman R. Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital J Antimicrob Chemother 52 2003 141-142 doi:10.1093/jac/dkg276
11. Wagenvoort J.H.T. Joosten E.J.A.J. An outbreak of Acinetobacter baumannii that mimics MRSA in its environmental longevity J Hosp Infect 52 2002 226-229 doi:10.1053/jhin.2001.1294
12. Corbella X. Montero A. Pujol M. et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii J Clin Microbiol 38 2000 4086-4095
13. Bayat A. Shaaban H. Dodgson A. Dunn K.W. Implications for burns unit design following outbreak of multi-resistant Acinetobacter infection in ICU and burns unit Burns 29 2003 303-306
14. Podnos Y.D. Cinat M.E. Wilson S.E. Cooke J. Gornick W. Thrupp L.D. Eradication of multi-drug resistant Acinetobacter from an intensive care unit Surg Infect (Larchmt) 2 2001 297-301
15. Livermore D.M. The impact of carbapenemases on antimicrobial development and therapy Curr Opin Investig Drugs 3 2002 218-224
16. Bou G. Cervero G. Dominguez M.A. Quereda C. Martinez-Beltran J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases J Clin Microbiol 38 2000 3299-3305
17. Fernadez-Cuenca F. Martinez-Martinez L. Conejo M.C. Ayala J.A. Perea E.J. Pascual A. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii J Antimicrob Chemother 51 2003 565-574
18. Nemec A. Dijkshoorn L. van der Reijden T.J.K. Long-term predominance of two pan-European clones among multiresistant Acinetobacter baumannii strains in the Czech Republic J Med Microbiol 53 2004 147-153
19. Van Dessel H. Dijkshoorn L. van der Reijden T. et al. Identification of new geographically widespread multiresistant Acinetobacter baumannii clones from European and South African hospitals Res Microbiol 155 2004 105-112
20. Manikal V.M. Landman D. Saurina G. Oydna E. Lal H. Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage Clin Infect Dis 31 2000 101-106
21. Ehrenstein B. Bernards A.T. Dijkshoorn L. et al. Acinetobacter species identification by using tRNA spacer fingerprinting J Clin Microbiol 34 1996 2414-2420
22. Vaneechoutte M. Dijkshoorn L. Tjernberg I. et al. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis J Clin Microbiol 33 1995 11-15
23. Kaufmann M.E. Pulsed-field gel electrophoresis In: Woodford N. Johnson A.P. (Eds.) Methods in molecular medicine 15: Molecular bacteriology: Protocols and clinical applications 1998 33-50 Humana Press New Jersey
24. Senda K. Arakawa Y. Ichiyama S. et al. PCR detection of metallo-β-lactamase gene (blaIMP) in Gram-negative rods resistant to broad-spectrum β-lactams J Clin Microbiol 34 1996 2909-2913
25. Tsakris A. Pournaras S. Woodford N. et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece J Clin Microbiol 38 2000 1290-1292
26. Afzal-Shah M. Woodford N. Livermore D.M. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii Antimicrob Agents Chemother 45 2001 583-588
27. Bou G. Oliver A. Martinez-Beltran J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain Antimicrob Agents Chemother 44 2000 1556-1561
28. Nemec A. De Baere T. Tjernberg I. Vaneechoutte M. van der Reijden T.J. Dijkshoorn L. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens Int J Syst Evol Microbiol 51 2001 1891-1899
29. Andrews J.M. for the BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method J Antimicrob Chemother 48 Suppl S1 2001 43-57
30. Henwood C.J. Gatward T. Warner M. et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J Antimicrob Chemother 49 2002 479-487
31. Dijkshoorn L. Ursing B.M. Ursing J.B. Strain, clone and species: comments on three basic concepts of bacteriology J Med Microbiol 49 2000 397-401
32. Berlau J. Aucken H. Malnick H. Pitt T.L. Distribution of Acinetobacter species on skin of healthy humans Eur J Clin Microbiol Infect Dis 18 1999 179-183
33. Kollef M.H. An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumonia Clin Infect Dis 36 2003 1119-1121
34. Go E.S. Urban C. Burns J. et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam Lancet 344 1994 1329-1332
35. Mahgoub S. Ahmed J. Glatt A.E. Completely resistant Acinetobacter baumannii strains Infect Control Hosp Epidemiol 23 2002 477-479
36. Woodford N. Reynolds R. Turton J. et al. Two widely-disseminated strains of Enterococcus faecalis highly-resistant to gentamicin and ciprofloxacin from bacteraemias in the United Kingdom and Ireland J Antimicrob Chemother 52 2003 711-714 doi:10.1093/jac/dkg408
37. Weller T.M. Mackenzie F.M. Forbes K.J. Molecular epidemiology of a large outbreak of multiresistant Klebsiella pneumoniae J Med Microbiol 46 1997 921-926